Patanjali

The Ruchi Gold oil maker's profit rose to Rs 309 crore (about $37 million) for the three months ended Sept. 30, from Rs 255 crore a year earlier

India is the world's largest importer and meets 70% of its vegetable oil demand through foreign sourcing

Patanjali Foods share price: Reports said Promoter entities Patanjali Ayurved, and Patanjali Parivahan were looking to sell up to 11 million shares in the company

The Delhi High Court on Friday sought the Centre's stand on a petition seeking action against the alleged misbranding of Patanjali's "Divya Dant Manjan" as a vegetarian product. The petitioner's counsel claimed that though the dental care product was being sold with a "green dot", symbolising that it was a vegetarian commodity, it contains fish extract, a non-vegetarian ingredient. Justice Sanjeev Narula issued notice to the Centre, the Food Safety and Standards Authority of India (FSSAI) as well as Patanjali, Divya Pharmacy, Yoga guru Ramdev and other related parties on the petition by lawyer Yatin Sharma. The law does not mandate declaration of a "drug" as vegetarian or non-vegetarian but the packaging of "Divya Dant Manjan" wrongly carries a "green dot", which qualifies as "misbranding" under the Drugs and Cosmetics Act, the petitioner's counsel argued. The matter would be heard next in November. Represented by advocates Swapnil Chaudhary and Prashant Gupta, the petitioner stat

'Rule 170 of Drugs and Cosmetic Rules 1945, which deals with prohibition of misleading advertisement of Ayurveda, Siddha or Unani drugs, shall remain in the statute book'

On the weekly chart, Patanjali has previously faced notable resistance near the Rs 1,700 level. However, despite challenging market conditions this week, the stock has experienced a significant break

Patanjali misleading ads case: The Supreme Court ordered IMA President RV Asokan to issue apology in leading newspapers and to cover its cost himself

With a strong presence in the hinterland, Patanjali Foods is positive about rural demand moving northwards in the coming quarter.

Licences for 14 Ayurvedic products by Patanjali and Divya Pharmacy were suspended by the Uttarakhand government. However, on July 1, the state government revoked its suspension order

Court says disparaging claims undermine ayurveda's credibility

The sale of 14 Ayurvedic medicines manufactured by Divya Pharmacy and Patanjali Ayurveda Limited has been banned by the Gautam Buddh Nagar administration. The Supreme Court on July 9 directed Patanjali Ayurved Ltd, founded by yoga guru Ramdev, to file an affidavit stating whether advertisements of its 14 products, whose manufacturing licences were initially suspended but later restored, have been withdrawn. The Uttarakhand State Licensing Authority had on April 15 issued an order suspending the manufacturing licences of 14 products of Patanjali Ayurved Ltd and Divya Pharmacy. The Regional Ayurvedic and Unani Officer of Gautam Buddh Nagar issued the directive banning the 14 products on Friday, officials said. This action follows orders from the State Drug Licensing Authority, Ayurvedic and Unani Services, Uttarakhand, they said. According to information shared by the district information office, all medical practitioners and medical stores operating in the district have been inform

The Bombay High Court has directed Patanjali Ayurved to deposit Rs 50 lakh for alleged breach of the HC's interim order restraining it from selling its camphor products, in relation to a trademark infringement case filed by another company. Following trademark infringement allegations by Mangalam Organics Ltd, the HC in an interim order in August 2023 restrained Patanjali Ayurved Ltd from selling its camphor products. A single bench of Justice R I Chagla on July 8 noted that Patanjali, in an affidavit submitted in June, admitted breach of the earlier order granting injunction against sale of the impugned camphor products. "Such persistent breach of the injunction order dated 30th August 2023 by defendant no. 1 (Patanjali) cannot be tolerated by this court," Justice Chagla said in the order, a copy of which was made available on Wednesday. The bench said it would be appropriate to direct Patanjali to deposit a sum of Rs 50 lakh prior to passing of an order for contempt/breach of the

Patanjali tells Supreme Court it has stopped selling 14 products whose manufacturing licences were suspended in Uttarakhand

The company has also entered a licensing agreement with Patanjali Ayurved for a 3 per cent turnover-based fee

On the weekly chart, Mahindra Logistics stock prices have confirmed a bullish reversal pattern breakout known as the Cup and Handle

A case in this regard was registered in 2021 after reports found the samples did not meet the food safety standards

An interim stay was put on Friday on the implementation of an order suspending manufacturing licences of more than a dozen medicines of Patanjali Ayurved Ltd and Divya Pharmacy. The interim stay is being imposed with immediate effect on the basis of a preliminary inquiry report of a high level committee, Pankaj Kumar Pandey, Secretary Ayush, Uttarakhand government said in an order. "The order of the suspension is illegal and should not have been passed by the licensing authority in the manner it has been passed," the committee looking into the matter said in its report. The firms had challenged the last month's suspension order of the Uttarakhand state licensing authority. "Since the licence has been cancelled without following the procedure established by law, the committee is submitting its report to the government of Uttarakhand for appropriate decision," it said. The State Licensing Authority, Ayurvedic and Unani Services had suspended the manufacturing licence of 14 Patanjali

The Ruchi Gold oil maker's profit fell to Rs 206 crore (around $25 million) for the quarter ended March 31, from Rs 264 crore a year earlier

The court is hearing a petition filed by the Indian Medical Association (IMA) against Patanjali's advertisements attacking allopathy and making claims about curing certain diseases

IMA President Dr RV Asokan drew sharp criticism from the Supreme Court for his remarks concerning the court's ruling in a case involving misleading advertisements by Patanjali Ayurved